New insights into lung cancer

Prof. Dr. Paul Hofman, Head of the Laboratory of Clinical and Experimental Pathology at the University Hospital Nice, France, comments on his research in lung cancer, the promise of immuno-therapies and the role of next-generation sequencing technologies in cancer research.